MOLECULAR-FORM AND SUBCELLULAR-DISTRIBUTION OF ACID BETA-GALACTOSIDASE IN FIBROBLASTS FROM PATIENTS WITH G(M1) GANGLIOSIDOSIS, MORQUIO-B-DISEASE AND GALACTOSIALIDOSIS
N. Takiyama et al., MOLECULAR-FORM AND SUBCELLULAR-DISTRIBUTION OF ACID BETA-GALACTOSIDASE IN FIBROBLASTS FROM PATIENTS WITH G(M1) GANGLIOSIDOSIS, MORQUIO-B-DISEASE AND GALACTOSIALIDOSIS, Brain & development, 19(2), 1997, pp. 126-130
The molecular form and subcellular distribution of acid beta-galactosi
dase in cultured fibroblasts from patients with beta-galactosidase def
iciency (G(M1)-gangliosidosis, Morquio B disease and galactosialidosis
) were studied, using antibodies against three different forms of the
human enzyme: a high-molecular-weight multienzymic complex, a recombin
ant 84-kDa precursor, and a 61--kDa tryptic product of the precursor.
The mature enzyme from normal fibroblasts was immunoprecipitated by th
e anti-complex and anti-64-kDa protein antibodies, but not by the anti
-84-kDa precursor one, Immunofluorescence staining of normal fibroblas
ts revealed the granular (lysosomal) distribution with anti-64-kDa pro
tein antibody and the perinuclear reticular distribution with anti-84-
kDa precursor antibody, probably representing the Golgi apparatus. Bot
h patterns were demonstrated in Morquio B disease, but the residual en
zyme activity was exclusively due to the mature enzyme, In Type 1 gala
ctosialidosis, most of the expressed enzyme was detected as the precur
sor form with a perinuclear reticular distribution. In Type 2 galactos
ialidosis, more than half of the enzyme activity was due to the mature
form with a lysosomal distribution. Fibroblasts from a patient with C
-M1 gangliosidosis, expressing no beta-galactosidase mRNA, did not rea
ct against either anti-64-kDa protein antibody or anti-84-kDa precurso
r antibody. The combined use of Immunoprecipitation and immunostaining
was useful for analysing the pathophysiology of the intracellular pro
cessing and transport of the mutant beta-galactosidase. (C) 1997 Elsev
ier Science B.V.